Stephens Inc’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,203
Closed -$294K 1385
2021
Q4
$294K Sell
3,203
-1,274
-28% -$152K ﹤0.01% 1051
2021
Q3
$568K Sell
4,477
-824
-16% -$120K 0.01% 824
2021
Q2
$882K Sell
5,301
-10,946
-67% -$1.77M 0.01% 705
2021
Q1
$2.95M Sell
16,247
-1,203
-7% -$279K 0.05% 362
2020
Q4
$3.49M Buy
17,450
+15,427
+763% +$3.14M 0.06% 308
2020
Q3
$444K Buy
2,023
+435
+27% +$92.1K 0.01% 762
2020
Q2
$303K Sell
1,588
-835
-34% -$146K 0.01% 834
2020
Q1
$376K Sell
2,423
-703
-22% -$81.8K 0.01% 718
2019
Q4
$262K Sell
3,126
-2,687
-46% -$204K 0.01% 920
2019
Q3
$394K Buy
5,813
+368
+7% +$24.2K 0.01% 822
2019
Q2
$362K Buy
5,445
+1,033
+23% +$60.2K 0.01% 849
2019
Q1
$245K Buy
+4,412
New +$269K 0.01% 987

Other funds holding TDOC

Stephens Inc's TDOC Position: Q1 2022 in Review

Stephens Inc sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 3,203 shares — an estimated $294K sold.

Stephens Inc first reported a position in TDOC in Q1 2019 and held it in 12 quarters. The position peaked at $3.49M in Q4 2020. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Stephens Inc reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Stephens Inc sold 3,203 Teladoc Health shares in Q1 2022, an estimated $294K.
  • Stephens Inc first reported a position in Teladoc Health in Q1 2019 and held it in 12 quarters.
  • Stephens Inc's Teladoc Health position peaked at $3.49M in Q4 2020.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Stephens Inc's 13F filing for Q1 2022, filed 4 May 2022.